Effect of roxarsone inclusion in the diet on the performance and hepatic lipid metabolism of laying Tsaiya duck.
1. The aim of this study was to examine the effects of roxarsone (3-nitro-4-hydroxyphenylarsonic acid) inclusion in the diet on the performance, liver function and lipid metabolism in the liver of laying Brown Tsaiya ducks. 2. Sixty 36-week-old laying ducks were selected and allocated at random into 4 dietary treatments with 3 replications for each treatment. Feeding was for 7 weeks with 3 weeks of experimental diets followed by a 4 week withdrawal period. The experimental diets were supplemented with 0, 50, 100 and 300 mg/kg roxarsone, respectively 3. Dietary inclusion of 50 or 100 mg/kg roxarsone did not significantly promote performance. Inclusion of 300 mg/kg significantly depressed (P<0.05) performance, liver weight and content, serum triacylglycerol (TG), serum nonesterified fatty acid (NEFA) and increased (P<0.05) cholesterol, creatine kinase (CK) and aspartate aminotransferase (AST) in the serum at the end of 3 weeks on the experimental diet. 4. Laying characteristics returned to normal 4 weeks after withdrawal of roxarsone. The liver weight, fat and TG in the liver and serum concentrations of TG, NEFA, high density lipoprotein (HDL) and AST increased significantly (P<0.05), while the level of very low density lipoprotein (VLDL) decreased (P<0.05) at the end of the withdrawal period. More prominent vacuolised hepatic fatty cells were observed in laying ducks treated with 300 mg/kg of roxarsone.
Chen
K L
KL
National Chia-Yi University, Taiwan.
Wu
C P
CP
Chiou
P W
PW
D000818:Animals; D001219:Aspartate Aminotransferases / Q000097:blood; D001835:Body Weight; D002784:Cholesterol / Q000097:blood; D003049:Coccidiostats / Q000494:pharmacology*; D003402:Creatine Kinase / Q000097:blood; D004372:Ducks / Q000254:growth & development / Q000378:metabolism / Q000502:physiology*; D004435:Eating / Q000502:physiology; D004531:Eggs; D005227:Fatty Acids / Q000097:blood; D005234:Fatty Liver / Q000473:pathology; D005260:Female; D007770:L-Lactate Dehydrogenase / Q000097:blood; D016014:Linear Models; D050356:Lipid Metabolism; D008074:Lipoproteins / Q000097:blood; D008099:Liver / Q000737:chemistry / Q000473:pathology / Q000502:physiology*; D010058:Oviposition / Q000502:physiology; D011897:Random Allocation; D012406:Roxarsone / Q000494:pharmacology*; D012709:Serum Albumin / Q000032:analysis; D014280:Triglycerides / Q000097:blood
D003049:Coccidiostats; D005227:Fatty Acids; D008074:Lipoproteins; D012709:Serum Albumin; D014280:Triglycerides; D002784:Cholesterol; D007770:L-Lactate Dehydrogenase; D001219:Aspartate Aminotransferases; D003402:Creatine Kinase; D012406:Roxarsone